Citadel Advisors’s KraneShares MSCI All China Health Care Index ETF KURE Stock Holding History

Citadel Advisors’s Portfolio KURE Stock Details KURE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$947K	Buy	55,460 +31,388	+130%	+$556K	﹤0.01%	7783
2025 Q4	$410K	Sell	24,072 -11,474	-32%	-$219K	﹤0.01%	9489
2025 Q3	$744K	Buy	+35,546	New	+$699K	﹤0.01%	8197
2023 Q3	–	Sell	-11,463	Closed	-$207K	–	14732
2023 Q2	$207K	Buy	+11,463	New	+$229K	﹤0.01%	9816
2022 Q4	–	Sell	-22,209	Closed	-$394K	–	15200
2022 Q3	$394K	Sell	22,209 -1,483	-6%	-$30.9K	﹤0.01%	8975
2022 Q2	$554K	Buy	23,692 +1,513	+7%	+$31.8K	﹤0.01%	8422
2022 Q1	$517K	Sell	22,179 -22,231	-50%	-$546K	﹤0.01%	9311
2021 Q4	$1.27M	Buy	+44,410	New	+$1.53M	﹤0.01%	7305
2021 Q3	–	Sell	-14,265	Closed	-$650K	–	14270
2021 Q2	$650K	Buy	+14,265	New	+$607K	﹤0.01%	9417
2020 Q1	–	Sell	-11,944	Closed	-$276K	–	9919
2019 Q4	$276K	Buy	+11,944	New	+$271K	﹤0.01%	7718

Other funds holding KURE

VMPIC

Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return

OMC

Old Mission Capital Chicago, Illinois $6.3B AUM 14.68% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

SWM

Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return

GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

OWP

ORG Wealth Partners Dallas, Texas $667M AUM 45.16% 1-Year Est. Return

Citadel Advisors's KURE Position: Q1 2026 in Review

Citadel Advisors increased its KraneShares MSCI All China Health Care Index ETF (KURE) stake by 130% in Q1 2026, buying an estimated $556K and bringing the position to 55,460 shares worth $947K. The position accounts for ﹤0.01% of the portfolio, ranked #7783.

Citadel Advisors first reported a position in KURE in Q4 2019 and has held it in 10 quarters since. The position peaked at $1.27M in Q4 2021. 16 funds tracked by Wall St. Rank hold KURE as of Q1 2026.

Citadel Advisors held 55,460 shares of KraneShares MSCI All China Health Care Index ETF worth $947K as of Q1 2026.
Citadel Advisors bought 31,388 KraneShares MSCI All China Health Care Index ETF shares in Q1 2026, an estimated $556K.
KraneShares MSCI All China Health Care Index ETF made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #7783 holding.
Citadel Advisors first reported a position in KraneShares MSCI All China Health Care Index ETF in Q4 2019 and has held it in 10 quarters since.
Citadel Advisors's KraneShares MSCI All China Health Care Index ETF position peaked at $1.27M in Q4 2021.
16 funds tracked by Wall St. Rank held KraneShares MSCI All China Health Care Index ETF as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.